Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Baxter
AstraZeneca
Fuji
US Department of Justice
Cipla
McKesson
Boehringer Ingelheim
Queensland Health

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071472

« Back to Dashboard

NDA 071472 describes CYTARABINE, which is a drug marketed by Fresenius Kabi Usa, Hong Kong, Hospira, Mylan Labs Ltd, Teva Parenteral, and West-ward Pharms Int, and is included in fourteen NDAs. It is available from four suppliers. Additional details are available on the CYTARABINE profile page.

The generic ingredient in CYTARABINE is cytarabine. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cytarabine profile page.
Summary for 071472
Tradename:CYTARABINE
Applicant:West-ward Pharms Int
Ingredient:cytarabine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 071472

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/VIAL
Approval Date:Aug 2, 1989TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Citi
Queensland Health
Cantor Fitzgerald
UBS
Johnson and Johnson
Chubb
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.